Bhanu P Venkatesulu
Overview
Explore the profile of Bhanu P Venkatesulu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Podgorsak A, Venkatesulu B, Abuhamad M, Harkenrider M, Solanki A, Roeske J, et al.
Brachytherapy
. 2023 Jun;
22(5):686-696.
PMID: 37316376
Purpose: Target and organ delineation during prostate high-dose-rate (HDR) brachytherapy treatment planning can be improved by acquiring both a postimplant CT and MRI. However, this leads to a longer treatment...
2.
Saripalli A, Lee B, Adams W, Bhandare N, Venkatesulu B, Yoo R, et al.
Int J Radiat Oncol Biol Phys
. 2023 May;
117(3):630-640.
PMID: 37201758
Purpose: Molecular imaging better identifies anatomic regions of metastatic spread of prostate cancer compared with conventional imaging, resulting in para-aortic (PA) nodal metastases being increasingly identified. Consequently, some radiation oncologists...
3.
Upadhyay R, Yadav D, Venkatesulu B, Singh R, Baliga S, Raval R, et al.
Front Oncol
. 2022 Aug;
12:893855.
PMID: 36033525
Background: Central nervous system tumors are now the most common primary neoplasms seen in children, and radiation therapy is a key component in management. Secondary malignant neoplasms (SMNs) are rare,...
4.
Kim H, Venkatesulu B, McMillan M, Verma V, Lin S, Chang J, et al.
Int J Radiat Oncol Biol Phys
. 2022 Aug;
114(4):676-683.
PMID: 35973624
Purpose: The successes of local therapy for oligometastatic cancers cannot be extrapolated to oligoprogressive disease (OPD) because they are distinct clinical entities. Given the limited prospective data on OPD to...
5.
Bhattarai S, Mackeyev Y, Venkatesulu B, Krishnan S, Singh P
Nanoscale
. 2021 Nov;
13(45):19056-19065.
PMID: 34757363
CXC chemokine receptor 4 (CXCR4) is overexpressed on most breast cancer cell surfaces including triple negative breast cancer (TNBC) which lacks traditional receptor overexpression. We targeted gold nanoparticles (GNPs) to...
6.
Venkatesulu B, Lester S, Hsieh C, Verma V, Sharon E, Ahmed M, et al.
JNCI Cancer Spectr
. 2021 Jan;
5(1):pkaa103.
PMID: 33437924
The coronavirus disease-2019 (COVID-19) pandemic caused by SARS-CoV-2 has exacted an enormous toll on healthcare systems worldwide. The cytokine storm that follows pulmonary infection is causally linked to respiratory compromise...
7.
Dilmanian F, Venkatesulu B, Sahoo N, Wu X, Nassimi J, Herchko S, et al.
Br J Radiol
. 2020 Jan;
93(1107):20190332.
PMID: 31944824
Proton minibeam therapy (PMBT) is a form of spatially fractionated radiotherapy wherein broad beam radiation is replaced with segmented minibeams-either parallel, planar minibeam arrays generated by a multislit collimator or...
8.
Singh P, Deorukhkar A, Venkatesulu B, Li X, Tailor R, Bomalaski J, et al.
Mol Cancer Ther
. 2019 Aug;
18(12):2381-2393.
PMID: 31395686
Distinct metabolic vulnerabilities of cancer cells compared with normal cells can potentially be exploited for therapeutic targeting. Deficiency of argininosuccinate synthetase-1 (ASS1) in pancreatic cancers creates auxotrophy for the semiessential...
9.
Chadha A, Gunther J, Hsieh C, Aliru M, Mahadevan L, Venkatesulu B, et al.
Radiother Oncol
. 2019 Apr;
133:54-61.
PMID: 30935582
Background And Purpose: This study documents the utilization and efficacy of proton beam therapy (PBT) in western patients with localized unresectable hepatocellular carcinoma (HCC). Methods And Methods: Forty-six patients with...
10.
Adhikari N, Kumar P, Venkatesulu B, Pandey R, Haresh K, Gupta S, et al.
J Glob Oncol
. 2018 Sep;
4:1-4.
PMID: 30241172
No abstract available.